American journal of perinatology · 2026
Iron Deficiency Screening with Reticulocyte-Hemoglobin Content and 2-Year Neurodevelopmental Outcomes in Extremely Low Birth Weight Infants.
СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hulse Whitley N, Bahr Timothy M, Ostrander Betsy, Winter Sarah, Ohls Robin K, DuPont Tara L
Аннотация
OBJECTIVE: The objective of this study is to assess reticulocyte-hemoglobin (RET-He) and daily iron dosing with 2-year cognitive outcomes.
STUDY DESIGN: A multicenter retrospective cohort study of 78 infants born between 2014 and 2018 at less than 28 weeks' gestation or less than 1,250 g birth weight throughout level III or IV neonatal intensive care units (NICUs). RET-He measurement, iron supplementation, and the Bayley Scales of Infant and Toddler Development-III (Bayley-III) test were analyzed using multiple linear regression models.
RESULTS: For every 1 mg/kg increase in mean total daily iron supplementation, the Bayley-III cognitive score increased by 2.9 points (95% confidence interval [CI]: 0.4-5.4, p = 0.023). No associations were identified between minimum or maximum RET-He and Bayley-III cognitive outcomes. Infants with a RET-He value < 29 pg tended to be 2.53 times more likely to have a Bayley-III language score below 70 (odds ratio: 2.53, 95% CI: 0.92-6.95, p = 0.071). Thirty-eight out of 78 (38.4%) infants were iron-deficient during their NICU hospitalization, with at least one RET-He < 29 pg.
CONCLUSION: An association was identified between a higher mean daily iron dose and improved cognitive outcomes for infants, but not between the iron index RET-He and neurodevelopmental outcomes. Iron deficiency remains common among NICU patients undergoing follow-up, suggesting that standard iron dosing may be inadequate for high-risk neonates.
KEY POINTS: · Higher daily iron dose improves cognitive outcomes.. · Reticulocyte-hemoglobin level is not associated with neurodevelopmental outcomes.. · Iron deficiency is common in very low birth weight infants, affecting 38.4%..
STUDY DESIGN: A multicenter retrospective cohort study of 78 infants born between 2014 and 2018 at less than 28 weeks' gestation or less than 1,250 g birth weight throughout level III or IV neonatal intensive care units (NICUs). RET-He measurement, iron supplementation, and the Bayley Scales of Infant and Toddler Development-III (Bayley-III) test were analyzed using multiple linear regression models.
RESULTS: For every 1 mg/kg increase in mean total daily iron supplementation, the Bayley-III cognitive score increased by 2.9 points (95% confidence interval [CI]: 0.4-5.4, p = 0.023). No associations were identified between minimum or maximum RET-He and Bayley-III cognitive outcomes. Infants with a RET-He value < 29 pg tended to be 2.53 times more likely to have a Bayley-III language score below 70 (odds ratio: 2.53, 95% CI: 0.92-6.95, p = 0.071). Thirty-eight out of 78 (38.4%) infants were iron-deficient during their NICU hospitalization, with at least one RET-He < 29 pg.
CONCLUSION: An association was identified between a higher mean daily iron dose and improved cognitive outcomes for infants, but not between the iron index RET-He and neurodevelopmental outcomes. Iron deficiency remains common among NICU patients undergoing follow-up, suggesting that standard iron dosing may be inadequate for high-risk neonates.
KEY POINTS: · Higher daily iron dose improves cognitive outcomes.. · Reticulocyte-hemoglobin level is not associated with neurodevelopmental outcomes.. · Iron deficiency is common in very low birth weight infants, affecting 38.4%..